Trial Profile
A Single Center Pilot Study to Establish the 99mTc-EC-DG Imaging Protocol to Evaluate the Presence and Severity of Coronary Artery Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2014
Price :
$35
*
At a glance
- Drugs Tc 99m ethylenedicysteine deoxyglucose (Primary)
- Indications Coronary artery disease
- Focus Diagnostic use
- Sponsors CellPoint
- 27 May 2014 New trial record